In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.
Schmitz
Franz-Josef
FJ
Boos
Mechthild
M
Mayer
Susanne
S
Köhrer
Karl
K
Scheuring
Sibylle
S
Fluit
Ad C
AC
D000890:Anti-Infective Agents / Q000494:pharmacology*; D027101:DNA Topoisomerase IV / Q000378:metabolism; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D007211:Indoles; D008826:Microbial Sensitivity Tests; D015363:Quinolones; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000235:genetics
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D007211:Indoles; D015363:Quinolones; D027101:DNA Topoisomerase IV; C419689:garenoxacin